Inventor · disambiguated record
Dayanand Panpatil
Also filed as: PANPATIL DAYANAND
6 granted patents·11 pending applications·4 citations·filing 2018–2024
69Inventor score
Files withPraxis Biotech LLC13SPEROGENIX THERAPEUTICS LTD2BLACK BELT TX LTD1MOMENTUM THERAPEUTICS INC1
Top patents by PatentIndex Score
17 records- 0181US11166942B2Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2019·Granted Nov 9, 2021·2 cites·42 claims
- 0279US11504364B2Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2019·Granted Nov 22, 2022·2 cites·37 claims
- 0364US2023144841A1Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 0460US2022071966A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2021·Application pending·0 cites
- 0560US2025092031A1Ripk3 inhibitors and methods of useMOMENTUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0658US2023083885A1Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 0758US2023047589A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2021·Application pending·0 cites
- 0856US2023042881A1Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 0954US11230542B2Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2018·Granted Jan 25, 2022·0 cites·58 claims
- 1051US2025346587A1Nitrogen-containing five-membered heterocyclic derivatives as checkpoint kinase 1 inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1150US2021317102A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 1247US2020270232A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 1346US11318133B2Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Granted May 3, 2022·0 cites·45 claims
- 1443US2020216417A1Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 1542US11780821B2Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2018·Granted Oct 10, 2023·0 cites·16 claims
- 1638US12428395B2Heterocyclic compounds as kinase inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2020·Granted Sep 30, 2025·0 cites·18 claims
- 1736US2022017541A1Inhibitors of arginaseBLACK BELT TX LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dayanand Panpatil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →